CEVAMULINE 125 MG/ML, ORAL SOLUTION FOR USE IN DRINKING WATER FOR RABBITS
CEVAMULINE 125 MG/ML, ORAL SOLUTION FOR USE IN DRINKING WATER FOR RABBITS
Authorised
- Tiamulin hydrogen fumarate
Product identification
Medicine name:
CEVAMULINE 125 MG/ML, ORAL SOLUTION FOR USE IN DRINKING WATER FOR RABBITS
CEVAMULINE SOLUTION LAPIN
Active substance:
- Tiamulin hydrogen fumarate
Target species:
-
Rabbit
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Tiamulin hydrogen fumarate125.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral solution
Withdrawal period by route of administration:
-
Oral use
-
Rabbit
-
Meat and offal2day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01XQ01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Package description:
- Box containing 1 vial of 10 ml
- 5 litre bottle
- 2 litre bottle
- 1 litre bottle
- 500 ml bottle
- Box containing 1 vial of 100 ml
- Box containing 1 vial of 30 ml
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
- Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
- Ceva Sante Animale
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/9392718 9/2009
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0261/001
Concerned member states:
-
Italy
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 1/07/2025